From Solve Seed Funding to $3M NIH Grant for ME/CFS Research
Solve Ramsay Research Grant winner Dr. Lubov Nathanson and her team at Nova Southeastern University have been
June 25, 2026
Solve Ramsay Research Grant winner Dr. Lubov Nathanson and her team at Nova Southeastern University have been
Two recently published studies funded by Solve are pointing to gastrointestinal dysfunction as a key
Dr. Liisa Selin, Dr. Ayano Kohlgruber, and Dr. Roshan Kumar received a Solve ME/CFS Catalyst
When an organization, like a government agency, company, or nonprofit, considers a big change or
Glucagon-Like Peptide-1 (GLP-1) agonist medications, like semaglutide, are injectable or oral drugs that mimic the
In our “What’s New in ME/CFS?” series, we spotlight researchers transforming what we can do
Solve M.E. is proud to support two pioneering studies through our latest round of ME/CFS
Manuel Ruiz Pablos, at the Complutense University of Madrid, and Dr. Bruno Paiva, at the
Why do so many people with ME/CFS share the same immune gene variants? That’s the
Dear Friends, As this year comes to a close, I find myself thinking not just
One of the most promising signs of progress in ME/CFS science today? Multiple datasets, collected
Dr. Deborah Duricka is a professor at the University of Alaska; researcher at Neuroversion; and